Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
Clinical trial NCT05035030 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05035030
- Sponsor
- Albireo, an Ipsen Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-03
- Primary completion
- 2026-12-31
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.